PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Increased risk of hearing impairment with new thyroid eye disease treatment

Small study finds 65 percent of patients taking teprotumumab report otologic symptoms

2021-03-20
(Press-News.org) WASHINGTON--More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease, teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.

Teprotumumab, approved by the U.S. Food and Drug Administration in January 2020, is the first and only drug to be approved for thyroid eye disease. In two clinical trials conducted prior to FDA approval of the drug, otologic symptoms were reported in 10 percent of patients. The new study found the rate could be as high as 65 percent.

The treatment is administered to patients once every three weeks for a total of eight infusions. It has shown significant improvement in abnormal protrusion of the eyes (proptosis), double vision, soft tissue inflammation and quality of life.

Andrea Lora Kossler, M.D., assistant professor of ophthalmology at the Stanford University School of Medicine, is the senior author on the research. She and fellow researchers state that teprotumumab is an effective therapy for thyroid eye disease, but as with all therapeutics, there are known risks, including hearing impairment. The authors aim to better understand the risk of hearing loss and recommend tests to reduce this risk.

Thyroid eye disease is an autoimmune disease in which the eye muscles and fatty tissue behind the eye become inflamed. Symptoms can include dry, watery, red or bulging eyes, a "stare," double vision, difficulty closing the eyes, and problems with vision. It is primarily associated with an overactive thyroid gland due to Graves' disease.

To explore the incidence of hearing symptoms in patients treated with teprotumumab, the researchers evaluated 26 patients treated with at least four infusions of the drug. Seventeen patients (65 percent) complained of otologic symptoms when questioned. The most common symptoms were subjective hearing loss (n=6, 23 percent), tinnitus, or ringing in the ears (n=7, 27 percent), ear plugging sensation (n=3, 12 percent), and autophony, an unusually loud hearing of a person's own voice (29 percent). Otologic symptoms developed after an average of 3.6 infusions.

Of the 17 patients with new hearing symptoms, four had new or worsening sensorineural hearing loss, a type of hearing loss resulting from damaged hair cells in the inner ear. Three patients had patulous eustachian tube, a disorder in which the channel that runs between the middle ear and back of the nose and throat stays open. Normally, these eustachian tubes remain closed and open only occasionally to regulate air pressure around the ear drum. After three months, symptoms of patulous eustachian tube improved, but did not completely disappear. Two patients with sensorineural hearing loss had improvement in symptoms at one and six months.

The authors aim to raise awareness on the incidence of otologic symptoms & recommend screening precautions, such as baseline audiogram testing to better understand this potential side effect. The follow up period of 3 months after stopping the drug is too short to assess the reported reversibility of otologic symptoms. Future studies will evaluate risk factors for hearing loss and the reversibility of symptoms.

INFORMATION:

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.



ELSE PRESS RELEASES FROM THIS DATE:

Tubeless automated insulin delivery system improves blood glucose outcomes

2021-03-20
WASHINGTON--People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation's Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy. Results from an industry-sponsored study of the latest Omnipod, the first tubeless, wearable insulin pump, will be presented at ENDO 2021, the Endocrine Society's annual meeting. The Omnipod 5 System underwent three months of at-home testing in 128 adults and adolescents ages 14 to 70 years and 112 children ages 6 to less than 14 years. All study participants have type 1 diabetes and were first followed for two weeks using their standard therapy, either multiple daily insulin injections ...

'Hunger hormone' ghrelin affects monetary decision making

2021-03-20
WASHINGTON--Higher levels of the stomach-derived hormone ghrelin, which stimulates appetite, predict a greater preference for smaller immediate monetary rewards over larger delayed financial rewards, a new study finds. The study results will be presented at ENDO 2021, the Endocrine Society's annual meeting. This research presents novel evidence in humans that ghrelin, the so-called "hunger hormone," affects monetary decision making, said co-investigator Franziska Plessow, Ph.D., assistant professor of medicine at Massachusetts General Hospital and Harvard Medical School, Boston. She said recent research findings in rodents suggested that ghrelin may play a part in impulsive choices and behaviors. "Our results indicate that ghrelin might play a broader role than ...

Spanish-speaking children experience higher rate of obesity than English-speaking children

2021-03-20
WASHINGTON--Nearly one in five U.S. children and teenagers has obesity, and statistics show a higher prevalence of obesity in certain ethnicities, such as Hispanics and Blacks. Now results of a study being presented at ENDO 2021, the Endocrine Society's annual meeting, suggest that Spanish as a family's primary language is a predictor of childhood obesity, regardless of ethnicity. The prevalence of obesity among children and teens from Spanish-speaking households in the nation was 24.4 percent, approximately 50 percent higher than those from English-speaking households, according to results of a new analysis of the U.S. National Health and Nutrition Examination Survey. This survey examines a nationally representative sample ...

Real "doodles of light" in real-time mark leap for holograms at home

2021-03-20
Tokyo, Japan - Researchers from Tokyo Metropolitan University have devised and implemented a simplified algorithm for turning freely drawn lines into holograms on a standard desktop CPU. They dramatically cut down the computational cost and power consumption of algorithms that require dedicated hardware. It is fast enough to convert writing into lines in real-time, and makes crisp, clear images that meet industry standards. Potential applications include hand-written remote instructions superimposed on landscapes and workbenches. Flying cars, robots, spaceships...whatever sci-fi future you can imagine, there is always a common feature: holograms. ...

An easy way to reduce socioeconomic disparities

2021-03-20
Researchers from Columbia University and Temple University published a new paper in the Journal of Marketing that examines how choice architecture can reduce socioeconomic disparities. The study, forthcoming in the Journal of Marketing, is titled "Do Nudges Reduce Disparities? Choice Architecture Compensates for Low Consumer Knowledge" and is authored by Kellen Mrkva, Nathaniel Posner, Crystal Reeck, and Eric Johnson. As Mrkva explains, "Our research demonstrates that people with low socioeconomic status (SES), low numerical ability, and low knowledge are most impacted by nudges. As a result, 'good nudges,' designed to encourage ...

How our microplastic waste becomes 'hubs' for pathogens, antibiotic-resistant bacteria

How our microplastic waste becomes hubs for pathogens, antibiotic-resistant bacteria
2021-03-19
It's estimated that an average-sized wastewater treatment plant serving roughly 400,000 residents will discharge up to 2,000,000 microplastic particles into the environment each day. Yet, researchers are still learning the environmental and human health impact of these ultra-fine plastic particles, less than 5 millimeters in length, found in everything from cosmetics, toothpaste and clothing microfibers, to our food, air and drinking water. Now, researchers at New Jersey Institute of Technology have shown that ubiquitous microplastics can become 'hubs' for antibiotic-resistant bacteria ...

Lack of diversity in genomic databases may affect therapy selection for minority groups

2021-03-19
ROCHESTER, Minn. -- Low representation of minority groups in public genomic databases may affect therapy selection for Black patients with cancer, according to new Mayo Clinic research published in npj Precision Oncology. The researchers investigated the use of genomic databases and found that tumor mutation burden was significantly inflated in Black patients compared to White patients. As a result of the study, clinicians who are using public genomic databases need to be aware of the potential for inflated tumor mutation burden values and how that may affect therapy selection and outcomes, especially for patients from underrepresented groups. Clinicians use biomarkers, which are indicators of a disease or condition, to determine ...

Gene therapy using 'zinc fingers' may help treat Alzheimer's disease, animal study shows

2021-03-19
BOSTON - Researchers have used a genetic engineering strategy to dramatically reduce levels of tau--a key protein that accumulates and becomes tangled in the brain during the development of Alzheimer's disease--in an animal model of the condition. The results, which come from investigators at Massachusetts General Hospital (MGH) and Sangamo Therapeutics Inc., could lead to a potentially promising treatment for patients with this devastating illness. As described in Science Advances, the strategy involves a gene regulation technology called zinc finger protein transcription ...

Tiny machine poised to unlock brain's mysteries

Tiny machine poised to unlock brains mysteries
2021-03-19
A team of scientists, led by researchers at Northwestern University, Shirley Ryan AbilityLab and the University of Illinois at Chicago (UIC), has developed novel technology promising to increase understanding of how brains develop, and offer answers on repairing brains in the wake of neurotrauma and neurodegenerative diseases. Their research is the first to combine the most sophisticated 3-D bioelectronic systems with highly advanced 3-D human neural cultures. The goal is to enable precise studies of how human brain circuits develop and repair themselves in vitro. The study is the cover story for ...

Holographic microscopy illuminates pain-driven changes in neuronal network activity

Holographic microscopy illuminates pain-driven changes in neuronal network activity
2021-03-19
In a world first, a cross-institutional research collaboration has used a two-photon microscope (*1) with a combination of calcium imaging (*2) and holographic stimulation (*3) to reveal that the functional connectivity between neurons located in the primary somatosensory cortex is increased in response to acute pain. Pain occurs as a result of injury, such as peripheral neuron damage or inflammation stemming from peripheral tissue violation. Research findings have been published on the involvement of central nervous system abnormalities in the onset of pain and sustained pain. The primary somatosensory cortex ...

LAST 30 PRESS RELEASES:

Existing drug has potential for immune paralysis

Soft brainstem implant delivers high-resolution hearing

Uncovering the structural and regulatory mechanisms underlying translation arrest

Scientists develop strategy to improve flexible tandem solar cell performance

Pushing boundaries: Detecting the anomalous Hall effect without magnetization in a new class of materials

Generative AI’s diagnostic capabilities comparable to non-specialist doctors

Some patients may experience durable disease control even after discontinuing immune checkpoint inhibitors for side effects

Native American names extend the earthquake history of northeastern North America

Lake deposits reveal directional shaking during devastating 1976 Guatemala earthquake

How wide are faults?

Key enzyme in lipid metabolism linked to immune system aging

Improved smoking cessation support needed for surgery patients across Europe

Study finds women much more likely to be aware of and have good understanding of obesity drugs

Study details role of protein that may play a key role in the development of schizophrenia

Americans don’t think bird flu is a threat, study suggests

New CDC report shows increase in autism in 2022 with notable shifts in race, ethnicity, and sex

Modulating the brain’s immune system may curb damage in Alzheimer’s

Laurie Manjikian named vice president of rehabilitation services and outpatient operations at Hebrew SeniorLife

Nonalcoholic beer yeasts evaluated for fermentation activity, flavor profiles

Millions could lose no-cost preventive services if SCOTUS upholds ruling

Research spotlight: Deer hunting season linked to rise in non-hunting firearm incidents

Rice scientists uncover quantum surprise: Matter mediates ultrastrong coupling between light particles

Integrative approach reveals promising candidates for Alzheimer’s disease risk factors or targets for therapeutic intervention

A wearable smart insole can track how you walk, run and stand

Research expands options for more sustainable soybean production

Global innovation takes center stage at Rice as undergraduate teams tackle health inequities

NIST's curved neutron beams could deliver benefits straight to industry

Finding friendship at first whiff: Scent plays role in platonic potential

Consortium of Multiple Sclerosis Centers releases 2025 expert panel document on best practices in MS management

A cool fix for hot chips: Advanced thermal management technology for electronic devices

[Press-News.org] Increased risk of hearing impairment with new thyroid eye disease treatment
Small study finds 65 percent of patients taking teprotumumab report otologic symptoms